Rentabilité et investissement économique pour éliminer l'hépatite C chronique au Mexique
Summary In July 2020, the Mexican Government initiated the National Program for Elimination of Hepatitis C (HCV) under a procurement agreement, securing universal, free access to HCV screening, diagnosis and treatment for 2020–2022. This analysis quantifies the clinical and economic burden of HCV (MXN) under a continuation (or end) to the agreement. A modelling and […]
French 
English 
Spanish 
Russian 
Arabic